Comac Medical participates in exclusive discussion about the future of outsourcing regional and global trials
June 10, 2021

Comac Medical’s CCO (Chief Compliance Officer) Mrs. Tsvetelina Ivanova along with other clinical leaders from organisations like Mallinckrodt Pharmaceuticals, Amsterdam UMC, Peachtree and Julius Clinical will explore the emerging future of outsourcing regional and global trials and discuss overcoming concerns around perceived risks and inefficiencies when building tailor-made trial solutions.

This exclusive discussion covers other topics such as:

  • How to build an outsourcing strategy that will deliver greater design flexibility and closer working with industry expert KOL’s
  • Where to find the right partners who can deliver personalized access to local sites, patient populations and scientific support
  • Why developing a peer-to-peer approach with local experts results in patient-preferred trial designs, outcomes and deliverables

Sharing their expertise are:

  • Anne Marie Inglis, PhD, Senior Director, Clinical Operations, Mallinckrodt Pharmaceuticals
  • Prof. Dr. Philip Scheltens, Professor of Cognitive Neurology and Director of the Alzheimer Center, Amsterdam UMC
  • Tsvetelina Ivanova, Chief Compliance Officer, Comac Medical
  • Dr. Keith Coffee, SVPMedical and Scientific Affairs, Peachtree
  • Hans van Dijk, Chief Operating Officer, Julius Clinical

The event is part of the Reuters Pharma events and is free to access through the link: https://bit.ly/3eFGOVV